Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $42.5600 (-0.73%) ($42.4650 - $43.3400) on Thu. Aug. 31, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.99% (three month average) | RSI | 40 | Latest Price | $42.5600(-0.73%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.2% a day on average for past five trading days. | Weekly Trend | HALO declines -0.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) XBI(48%) IVW(40%) SPY(38%) XME(37%) IWO(36%) | Factors Impacting HALO price | HALO will decline at least -0.995% in a week (0% probabilities). INDA(-39%) VXX(-27%) TBT(-19%) OIH(-17%) VIXM(-15%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.995% (StdDev 1.99%) | Hourly BBV | -1.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $42.89 | 5 Day Moving Average | $42.71(-0.35%) | 10 Day Moving Average | $42.64(-0.19%) | 20 Day Moving Average | $42.89(-0.77%) | To recent high | -3.4% | To recent low | 31.3% | Market Cap | $5.817b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |